ARTICLE | Distillery Therapeutics
Therapeutics: Nemo-like kinase (NLK); androgen receptor
October 1, 2015 7:00 AM UTC
Cell culture and mouse studies suggest inhibiting NLK could help treat spinal and bulbar muscular atrophy (SBMA). In SBMA patients, polyglutamine repeats in mutant androgen receptors cause androgen re...